DHX9 and Ewing sarcoma: Downregulation of SRSF3 or hnRNPM can inhibit the expression of DHX9 and the proliferation of Ewing’s sarcoma cells, and enhance the sensitivity of Ewing’s sarcoma cells to chemotherapy (16).